Chuan Zhang Selected Research

Heart Failure

3/2024	Sacubitril/valsartan can improve the cardiac function in heart failure patients with a history of cancer: An observational study.
9/2022	Immune-related myocarditis in two patients receiving camrelizumab therapy and document analysis.
1/2019	Volatile anesthetics versus total intravenous anesthesia in patients undergoing coronary artery bypass grafting: An updated meta-analysis and trial sequential analysis of randomized controlled trials.
4/2015	hERG potassium channel blockade by the HCN channel inhibitor bradycardic agent ivabradine.
2/2015	[Association of T190C polymorphism of β3 adrenergic receptor gene with response to carvedilol in patients with chronic heart failure].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chuan Zhang Research Topics

Disease

75	Neoplasms (Cancer) 03/2024 - 07/2015
18	Inflammation (Inflammations) 04/2024 - 11/2003
16	Stroke (Strokes) 02/2024 - 06/2006
16	Neoplasm Metastasis (Metastasis) 01/2023 - 07/2007
16	Colorectal Neoplasms (Colorectal Cancer) 12/2022 - 01/2016
10	Osteosarcoma (Osteogenic Sarcoma) 01/2022 - 07/2016
9	Infections 03/2024 - 02/2005
9	Carcinogenesis 10/2023 - 01/2016
8	Hypoxia (Hypoxemia) 01/2023 - 11/2017
6	Gastroesophageal Reflux (GERD) 01/2023 - 12/2018
6	Phenylketonurias (Phenylketonuria) 01/2023 - 12/2014
5	Ischemic Stroke 04/2024 - 10/2017
5	Heart Failure 03/2024 - 02/2015
5	Melanoma (Melanoma, Malignant) 11/2023 - 01/2021
5	Non-alcoholic Fatty Liver Disease 04/2023 - 11/2012
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2006
5	Colitis 12/2021 - 12/2011
4	Lymphatic Metastasis 03/2024 - 05/2021
4	Pain (Aches) 03/2024 - 04/2022
4	Breast Neoplasms (Breast Cancer) 01/2024 - 01/2022
4	Wounds and Injuries (Trauma) 01/2023 - 01/2018
4	Body Weight (Weight, Body) 01/2023 - 01/2017
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 03/2017
4	Myocardial Infarction 12/2019 - 01/2006
3	Postoperative Pain 03/2024 - 07/2014
3	Ischemia 01/2024 - 01/2018
3	Ulcerative Colitis 01/2023 - 01/2020
3	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2023 - 01/2023
3	Hypertension (High Blood Pressure) 01/2023 - 11/2012
3	Type 2 Diabetes Mellitus (MODY) 01/2023 - 11/2012
3	Atrophy 01/2023 - 02/2005
3	Muscle Spasticity (Spastic) 01/2023 - 01/2020
3	Brain Ischemia (Cerebral Ischemia) 11/2022 - 01/2016
3	Cardiac Arrhythmias (Arrythmia) 09/2022 - 04/2015
3	Rheumatoid Arthritis 01/2022 - 05/2021
3	Hyperplasia 05/2021 - 01/2012
3	Colonic Neoplasms (Colon Cancer) 05/2021 - 08/2018
3	Hyperthermia 01/2021 - 01/2019
3	Congenital Abnormalities (Deformity) 01/2020 - 08/2017
3	Hyperglycemia 01/2016 - 01/2012
2	Rectal Neoplasms (Rectal Cancer) 04/2024 - 01/2022
2	Pathologic Constriction (Stenosis) 04/2024 - 01/2022

Drug/Important Bio-Agent (IBA)

15	DNA (Deoxyribonucleic Acid)IBA 03/2024 - 10/2017
12	Biomarkers (Surrogate Marker)IBA 03/2024 - 06/2002
11	Nucleic AcidsIBA 11/2023 - 05/2018
10	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2019
8	Therapeutic UsesIBA 04/2024 - 08/2017
8	MicroRNAs (MicroRNA)IBA 01/2024 - 01/2019
8	Botulinum Toxins (Botulinum Toxin)IBA 01/2023 - 01/2017
8	RNA (Ribonucleic Acid)IBA 01/2023 - 05/2018
7	AcidsIBA 04/2024 - 01/2018
7	Peptides (Polypeptides)IBA 02/2024 - 11/2017
7	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2024 - 11/2003
6	3,4-dihydroxyphenyllactic acidIBA 02/2024 - 01/2018
6	erucylphosphocholineIBA 01/2023 - 01/2016
6	Small Interfering RNA (siRNA)IBA 01/2022 - 12/2018
5	Indicators and Reagents (Reagents)IBA 04/2024 - 01/2015
5	Anti-Bacterial Agents (Antibiotics)IBA 03/2024 - 10/2017
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2024 - 07/2007
5	Phenylalanine Hydroxylase (Phenylalanine 4 Monooxygenase)IBA 01/2023 - 12/2014
5	CytokinesIBA 01/2023 - 01/2021
5	A-Form DNA (A-DNA)IBA 04/2022 - 08/2018
5	Circular RNAIBA 04/2022 - 01/2021
5	Long Noncoding RNAIBA 01/2022 - 01/2019
5	polyethylene glycol polyethyleneimine nanogelIBA 01/2022 - 01/2020
5	Oxygen (Dioxygen)IBA 10/2020 - 05/2004
4	Hematoxylin (Haematoxylon)IBA 01/2023 - 02/2005
4	Eosine Yellowish-(YS) (Eosin)IBA 01/2023 - 02/2005
4	EnzymesIBA 01/2022 - 06/2007
4	Amino Acids FDA Link 01/2022 - 12/2017
4	Insulin (Novolin)FDA Link 01/2017 - 01/2012
3	Hyaluronic Acid (Hyaluronan)IBA 04/2024 - 07/2007
3	VaccinesIBA 11/2023 - 05/2018
3	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2021
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2023 - 01/2006
3	Radioisotopes (Radionuclides)IBA 01/2022 - 01/2021
3	NucleosidesIBA 01/2022 - 07/2015
3	Pepsin A (Pepsin)IBA 08/2021 - 12/2018
3	Blood Glucose (Blood Sugar)IBA 01/2021 - 11/2012
3	Triglycerides (Triacylglycerol)IBA 12/2020 - 11/2012
3	Dextran SulfateIBA 11/2020 - 12/2011
3	ProdrugsIBA 01/2020 - 11/2017
3	NanogelsIBA 06/2019 - 05/2018
3	OzoneIBA 01/2018 - 04/2017
3	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2018 - 11/2017
3	Glucose (Dextrose)FDA LinkGeneric 01/2016 - 06/2005
3	astragaloside AIBA 07/2006 - 01/2006
2	Neuroprotective AgentsIBA 04/2024 - 01/2023

Therapy/Procedure

41	Therapeutics 04/2024 - 12/2011
16	Drug Therapy (Chemotherapy) 01/2023 - 01/2012
7	Injections 11/2023 - 01/2017
5	Immunotherapy 11/2023 - 08/2018
5	Denervation 01/2023 - 11/2003
5	Length of Stay 01/2019 - 09/2011
4	Intravenous Injections 01/2023 - 04/2019
3	Radiofrequency Ablation 01/2023 - 07/2019
3	Ligation 01/2019 - 01/2006
3	Osteotomy 10/2018 - 08/2017
3	Photochemotherapy (Photodynamic Therapy) 01/2018 - 11/2017
3	Catheters 01/2018 - 04/2017